E. Chaffeensis Ab IgG

<1:64
A normal or negative result for Ehrlichia chaffeensis Ab (IgG) typically indicates that there are no detectable IgG antibodies against Ehrlichia chaffeensis in the patient's blood. This suggests that the patient likely has not been exposed to the bacterium, which is responsible for human monocytic ehrlichiosis (HME), or that the exposure did not elicit a detectable immune response. However, a negative result could also mean that the infection is in its very early stages, and the body has not yet produced a significant level of IgG antibodies. It's also important to consider the possibility of a false negative, especially if the antibody levels are below the test's detection threshold. Therefore, while a normal result is helpful in ruling out a past or chronic E. chaffeensis infection, it should be interpreted within the broader context of the patient's symptoms, exposure history, and the timing of the test. Additional testing might be necessary if there is a strong suspicion of HME despite a negative IgG result.
=>1:64
An elevated result for Ehrlichia chaffeensis Ab (IgG) typically indicates that the patient has antibodies against Ehrlichia chaffeensis in their blood, suggesting past exposure or infection with the bacterium that causes human monocytic ehrlichiosis (HME). This result shows that the patient's immune system has responded to the pathogen. It can indicate either a past infection, as IgG antibodies can persist long after an infection has resolved, or a chronic or persistent infection, especially if the patient currently shows symptoms consistent with HME. However, a positive IgG test alone does not confirm an active infection. Therefore, it's important to interpret this result in the context of the patient's overall clinical history, symptoms, and potential tick exposure, and it may require further evaluation and testing for a complete understanding.

Ehrlichia chaffeensis antibody (IgG) testing is a critical diagnostic tool used to detect previous or ongoing infections with Ehrlichia chaffeensis, the bacterium responsible for human monocytic ehrlichiosis (HME), a potentially severe tick-borne disease.

The presence of IgG antibodies against E. chaffeensis in a patient's blood suggests an immune response to this specific pathogen. IgG antibodies are typically produced later in the course of an infection and can persist for a long period, often indicating past exposure or a more chronic form of the infection. In clinical settings, testing for E. chaffeensis IgG is particularly important for patients presenting with symptoms suggestive of HME, which include fever, headache, malaise, and sometimes more severe manifestations like thrombocytopenia, leukopenia, and elevated liver enzymes.

A positive IgG test result is significant as it helps in confirming the diagnosis of HME, especially in areas where ticks are prevalent, and in patients with a history of tick exposure. However, the interpretation of E. chaffeensis IgG results requires careful consideration. While a positive result indicates exposure to the bacterium, it does not necessarily confirm an active infection, as IgG antibodies can remain in the system long after the initial exposure. Thus, clinicians often assess these results alongside the patient's clinical history, symptomatology, and other laboratory findings. In some cases, additional testing for IgM antibodies, which are produced earlier in the infection, might be conducted for a more comprehensive understanding of the infection timeline. In summary, E. chaffeensis Ab (IgG) testing plays a vital role in diagnosing human monocytic ehrlichiosis, but the results must be evaluated in the context of the patient's overall clinical picture.

E. Chaffeensis Ab IgG
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond E. Chaffeensis Ab IgG — 10,000+ markers explained
One E. Chaffeensis Ab IgG result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro